Published in Curr Oncol on April 01, 2011
Diagnosis and Treatment of Mucinous Appendiceal Neoplasm Presented as Acute Appendicitis. Case Rep Oncol Med (2016) 1.44
A rare cause of ascites: pseudomyxoma peritonei and a review of the literature. Clin Case Rep (2014) 0.95
Cytoreductive surgery in combination with hyperthermic intraperitoneal chemotherapy improves survival in patients with colorectal peritoneal metastases compared with systemic chemotherapy alone. Br J Cancer (2014) 0.89
Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal metastases. World J Gastroenterol (2014) 0.87
The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma. Mod Pathol (2015) 0.82
Benign multicystic peritoneal mesothelioma: a rare tumour of the abdomen. Case Rep Surg (2015) 0.80
Does the expression of BCL2 have prognostic significance in malignant peritoneal mesothelioma? Am J Cancer Res (2013) 0.78
Repeat Cytoreductive Surgery and HIPEC for Peritoneal Surface Malignancy and Peritoneal Carcinomatosis. World J Surg (2015) 0.77
Surgical technology and pharmacology of hyperthermic perioperative chemotherapy. J Gastrointest Oncol (2016) 0.76
The Initial Indian Experience with Cytoreductive Surgery and HIPEC in the Treatment of Peritoneal Metastases. Indian J Surg Oncol (2016) 0.75
Potentiation of chemotherapeutics by bromelain and N-acetylcysteine: sequential and combination therapy of gastrointestinal cancer cells. Am J Cancer Res (2016) 0.75
Platelet Dynamics in Peritoneal Carcinomatosis Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Oxaliplatin. AAPS J (2015) 0.75
Progression of peritoneal adenomucinosis to the scrotum: a rare occurrence treated with cytoreductive surgery and hyperthermic chemoperfusion of the scrotum in two patients. Colomb Med (Cali) (2014) 0.75
Cytoreductive Surgery and Peritonectomy Procedures. Indian J Surg Oncol (2016) 0.75
Microspheres targeted with a mesothelin antibody and loaded with doxorubicin reduce tumor volume of human mesotheliomas in xenografts. BMC Cancer (2013) 0.75
Hemodynamic Monitoring During Heated Intraoperative Intraperitoneal Chemotherapy Using the FloTrac/Vigileo System. Int Surg (2015) 0.75
Morbidity and mortality of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in advanced gastric cancer. Transl Gastroenterol Hepatol (2016) 0.75
Patient-derived xenograft mouse models of pseudomyxoma peritonei recapitulate the human inflammatory tumor microenvironment. Cancer Med (2016) 0.75
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med (2004) 49.02
The heat-shock response. Annu Rev Biochem (1986) 20.16
Recurrence and survival after total mesorectal excision for rectal cancer. Lancet (1986) 8.16
Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol (2003) 7.57
Determining when quality improvement initiatives should be considered research: proposed criteria and potential implications. JAMA (2000) 5.26
Developing and testing changes in delivery of care. Ann Intern Med (1998) 4.55
Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol (2004) 4.15
Resection of hepatic metastases from colorectal cancer. Arch Surg (1984) 4.06
8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol (2008) 3.94
Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients. Ann Oncol (2002) 3.91
Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg (1995) 3.41
New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol (2006) 3.36
Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol (2008) 3.24
Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery (1986) 3.22
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol (2009) 3.04
Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res (1996) 3.00
Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol (2009) 2.99
Pseudomyxoma peritonei of appendiceal origin: a clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review. Am J Surg Pathol (2006) 2.82
Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741. J Clin Oncol (2008) 2.58
Complete mesocolic excision with central vascular ligation produces an oncologically superior specimen compared with standard surgery for carcinoma of the colon. J Clin Oncol (2009) 2.57
Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg (2007) 2.25
Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET. J Clin Oncol (2004) 2.23
Resection of the liver for colorectal carcinoma metastases. A multi-institutional study of long-term survivors. Dis Colon Rectum (1988) 2.20
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology. Ann Surg Oncol (2006) 2.13
Operative findings, early complications, and long-term survival in 456 patients with pseudomyxoma peritonei syndrome of appendiceal origin. Dis Colon Rectum (2011) 2.01
Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer (2001) 1.92
PET/CT: form and function. Radiology (2007) 1.89
Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinoma. Ann Oncol (2005) 1.71
A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei. Ann Surg Oncol (2006) 1.69
Early results of surgery in 123 patients with pseudomyxoma peritonei from a perforated appendiceal neoplasm. Dis Colon Rectum (2007) 1.62
Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer. J Am Coll Surg (2006) 1.57
Malignant peritoneal mesothelioma: treatment with maximal cytoreductive surgery plus intraperitoneal chemotherapy. Gastroenterol Clin Biol (2007) 1.52
Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal mesothelioma. Eur J Surg Oncol (2008) 1.46
Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonei: a prospective study. Dis Colon Rectum (2005) 1.44
Epithelial appendiceal neoplasms. Cancer J (2009) 1.44
Peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy: results of a prospective study. Ann Surg Oncol (2006) 1.42
Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis. Semin Surg Oncol (1998) 1.42
Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma: outcomes of an expanded access program. Clin Lung Cancer (2005) 1.39
Lymph node metastases in diffuse malignant peritoneal mesothelioma. Ann Surg Oncol (2009) 1.38
Diagnosis and treatment of peritoneal mesothelioma: The Washington Cancer Institute experience. Semin Oncol (2002) 1.34
Surgery for colorectal cancer metastatic to the liver. Optimizing the results of treatment. Surg Clin North Am (1989) 1.33
Comprehensive management of diffuse malignant peritoneal mesothelioma. Eur J Surg Oncol (2006) 1.33
For the clinical application of thermochemotherapy given at mild temperatures. Int J Hyperthermia (1999) 1.27
Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant vs. delayed management. Dis Colon Rectum (2000) 1.23
Abdominal computed tomographic scan in the selection of patients with mucinous peritoneal carcinomatosis for cytoreductive surgery. J Am Coll Surg (1995) 1.15
Learning curve for cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal surface malignancy--a journey to becoming a Nationally Funded Peritonectomy Center. Ann Surg Oncol (2007) 1.15
Morbidity and mortality with cytoreductive surgery and intraperitoneal chemotherapy: the importance of a learning curve. Cancer J (2009) 1.14
A phase II study evaluating the use of concurrent mitomycin C and capecitabine in patients with advanced unresectable pseudomyxoma peritonei. Br J Cancer (2008) 1.13
Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion. Ann Surg Oncol (2006) 1.12
Biological and clinical aspects of hyperthermia in cancer therapy. Am J Clin Oncol (1988) 1.09
Histopathologic analysis in 46 patients with pseudomyxoma peritonei syndrome: failure versus success with a second-look operation. Mod Pathol (2001) 1.09
Peritoneal surface disease from colorectal cancer: comparison with the hepatic metastases surgical paradigm in optimally resected patients. Ann Surg Oncol (2008) 1.06
Pharmacokinetics and pharmacodynamics of perioperative cancer chemotherapy in peritoneal surface malignancy. Cancer J (2009) 1.04
Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Br J Surg (2008) 1.03
Clinical results of cytoreduction and HIPEC for malignant peritoneal mesothelioma. Cancer Treat Res (2007) 1.03
Establishment of a peritoneal malignancy treatment centre in the United Kingdom. Eur J Surg Oncol (2006) 1.03
Systemic chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer. Cancer Treat Res (2007) 1.02
Hyperthermia in cancer therapy: the biological basis and unresolved questions. Cancer Res (1985) 1.02
Hyperthermic intraperitoneal doxorubicin: pharmacokinetics, metabolism, and tissue distribution in a rat model. Cancer Chemother Pharmacol (1998) 1.02
Prognostic significance of histomorphologic parameters in diffuse malignant peritoneal mesothelioma. Arch Pathol Lab Med (2006) 1.00
Pseudomyxoma peritonei: new concepts in diagnosis, origin, nomenclature, and relationship to mucinous borderline (low malignant potential) tumors of the ovary. Anat Pathol (1997) 0.99
Intraperitoneal chemotherapy for ovarian carcinoma: results of long-term follow-up. J Clin Oncol (2002) 0.99
(18)F-FDG-PET/CT to select patients with peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol (2009) 0.96
Systemic chemotherapy in the management of malignant peritoneal mesothelioma. Eur J Surg Oncol (2006) 0.93
Regional chemotherapy (with mitomycin C) and intra-operative hyperthermia for digestive cancers with peritoneal carcinomatosis. Hepatogastroenterology (1994) 0.93
A historical perspective on colorectal liver metastases and peritoneal carcinomatosis: similar results, different treatments. Surg Oncol Clin N Am (2003) 0.92
Use of the Cusum technique for evaluation of a CT-based navigation system for total knee replacement. Clin Orthop Relat Res (2004) 0.89
[Peritoneal carcinomatosis. Surgical treatment, peritonectomy and intraperitoneal chemohyperthermia]. Gastroenterol Clin Biol (2002) 0.87
Learning curve in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Surg Oncol (2009) 0.86
Pseudomyxoma peritonei: role of 18F-FDG PET in preoperative evaluation of pathological grade and potential for complete cytoreduction. Eur J Surg Oncol (2009) 0.81
Comparison of optimally resected hepatectomy and peritonectomy patients with colorectal cancer metastasis. J Surg Oncol (2009) 0.81
Successful antiangiogenic combination therapy for pseudomyxoma peritonei with bevacizumab and capecitabine. Cancer Biol Ther (2009) 0.81
Experience with adjuvant chemotherapy for pseudomyxoma peritonei secondary to mucinous adenocarcinoma of the appendix with oxaliplatin/fluorouracil/leucovorin (FOLFOX4). World J Surg Oncol (2008) 0.81
Current options for systemic therapy in mesothelioma. Semin Thorac Cardiovasc Surg (2009) 0.80
Clinical research to standard of care: when does the transition occur? Ann Surg Oncol (2003) 0.79
Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: the Australian experience. J Surg Oncol (2009) 0.78
Quality assessment of randomized controlled trials involving liver surgery. Hepatogastroenterology (2008) 0.77
Adenovirus E1A coding sequences that enable ras and pmt oncogenes to transform cultured primary cells. Mol Cell Biol (1986) 2.70
Partial nodular transformation of the liver with portal hypertension. Am J Med (1966) 2.45
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology. Ann Surg Oncol (2006) 2.13
The rationale behind complete mesocolic excision (CME) and a central vascular ligation for colon cancer in open and laparoscopic surgery : proceedings of a consensus conference. Int J Colorectal Dis (2014) 1.69
Comparisons between sublingual and gastric tonometry during hemorrhagic shock. Chest (2000) 1.62
The value of USP public standards for therapeutic products. Pharm Res (2004) 1.54
The use of preoperative plasma CEA levels for the Stratification of patients after curative resection of colorectal cancers. Ann Surg (1980) 1.45
Megakaryocytes derived from human embryonic stem cells: a genetically tractable system to study megakaryocytopoiesis and integrin function. J Thromb Haemost (2006) 1.45
Preoperative MRI sphincter morphology and anal manometry: can they be markers of functional outcome following anterior resection for rectal cancer? Colorectal Dis (2012) 1.44
Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome induced by cidofovir. Pediatr Transplant (2010) 1.39
CT in pseudomyxoma peritonei: a review of 17 cases. Clin Radiol (2002) 1.37
Results of multimodality therapy of resectable soft-tissue sarcomas of the retroperitoneum. Surgery (1985) 1.30
Prospective randomized evaluation of adjuvant chemotherapy in adults with soft tissue sarcomas of the extremities. Cancer (1983) 1.14
Tight junction assembly during mouse blastocyst formation is regulated by late expression of ZO-1 alpha+ isoform. Development (1997) 1.14
A role for PKCtheta in outside-in alpha(IIb)beta3 signaling. J Thromb Haemost (2006) 1.13
A systematic review of cancer related patient outcomes after anterior resection and abdominoperineal excision for rectal cancer in the total mesorectal excision era. Surg Oncol (2011) 1.10
Peritoneal carcinomatosis from gastrointestinal malignancy: natural history and new prospects for management. Acta Chir Belg (1994) 1.08
Identifying the early genetic consequences of habitat degradation in a highly threatened tropical conifer, Araucaria nemorosa Laubenfels. Mol Ecol (2007) 1.07
Recombinant tissue plasminogen activator increases blood-brain barrier disruption in acute ischemic stroke: an MR imaging permeability study. AJNR Am J Neuroradiol (2009) 1.03
Current treatment options and biology of peritoneal mesothelioma: meeting summary of the first NIH peritoneal mesothelioma conference. Ann Oncol (2006) 1.00
One millimetre is the safe cut-off for magnetic resonance imaging prediction of surgical margin status in rectal cancer. Br J Surg (2011) 0.95
Comparative quality of life in patients following abdominoperineal excision and low anterior resection for low rectal cancer. Dis Colon Rectum (2012) 0.93
Elevated tumour markers prior to complete tumour removal in patients with pseudomyxoma peritonei predict early recurrence. Colorectal Dis (2005) 0.93
Quantitative and qualitative aspects of radiolocalization in colon cancer patients of intravenously administered MAb B72.3. Int J Cancer (1987) 0.93
Long-term storage and safe retrieval of DNA from microorganisms for molecular analysis using FTA matrix cards. J Microbiol Methods (2006) 0.92
The dependence of quorum sensing on the depth of a growing biofilm. Bull Math Biol (2003) 0.91
A system to impose prescribed homogenous strains on cultured cells. J Appl Physiol (1985) (2001) 0.90
A randomized, prospective trial of adjuvant chemotherapy in adults with soft tissue sarcomas of the head and neck, breast, and trunk. Cancer (1985) 0.89
[Nasogastric tubes after elective abdominal surgery is not justified]. J Chir (Paris) (1998) 0.88
X-ray bang-time and fusion reaction history at picosecond resolution using RadOptic detection. Rev Sci Instrum (2012) 0.88
Quantitative analyses of selective radiolabeled monoclonal antibody localization in metastatic lesions of colorectal cancer patients. Cancer Res (1987) 0.88
Peritoneal metastases from colorectal cancer: patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol (2013) 0.87
A mathematical model of quorum sensing in a growing bacterial biofilm. J Ind Microbiol Biotechnol (2002) 0.87
Post-translational control of occludin membrane assembly in mouse trophectoderm: a mechanism to regulate timing of tight junction biogenesis and blastocyst formation. Development (2000) 0.87
Neoadjuvant chemotherapy in MRI-staged high-risk rectal cancer in addition to or as an alternative to preoperative chemoradiation? Ann Oncol (2012) 0.86
Complementation of intracavitary and intravenous administration of a monoclonal antibody (B72.3) in patients with carcinoma. Cancer Res (1987) 0.86
Digital compression of facial arteries facilitates cutaneous nasal surgery. Br J Dermatol (2013) 0.85
Radioimmunoscintigraphy of colon cancer with iodine-131-labeled B72.3 monoclonal antibody. J Nucl Med (1988) 0.84
Morphology of HRP-labelled cochlear nerve axons in the dorsal cochlear nucleus of the developing hamster. Hear Res (1992) 0.82
Anterior ankle arthrodesis with cross-screw fixation. A dowel graft method used in 20 cases. J Bone Joint Surg Br (1994) 0.80
Sites of surgical wasting in the abdominoperineal specimen. Br J Surg (2008) 0.79
Peritoneal carcinomatosis: imaging with intraperitoneal injection of I-131-labeled B72.3 monoclonal antibody. Radiology (1988) 0.79
The contribution of genetic factors to thrombotic and bleeding outcomes in coronary patients randomised to IIb/IIIa antagonists. Pharmacogenomics J (2002) 0.79
Clinical trials with a new intravenous liposoluble contrast material for computed tomography of the liver and spleen. Radiology (1980) 0.78
Segmental hyperlucent defects in the liver. J Comput Assist Tomogr (1984) 0.78
Radiolabeled monoclonal antibody B72.3 localization in metastatic lesions of colorectal cancer patients. Int J Rad Appl Instrum B (1987) 0.77
Differences in biodistribution of indium-111-and iodine-131-labeled B72.3 monoclonal antibodies in patients with colorectal cancer. J Nucl Med (1989) 0.77
Development of GAD-immunoreactivity in the dorsal cochlear nucleus of the hamster and cat: light and electron microscopic observations. Hear Res (1993) 0.77
Regulation of the vertebrate cell cycle by the cdc2 protein kinase. Cold Spring Harb Symp Quant Biol (1988) 0.76
Binding of radiolabeled MAb B72.3 administered intravenously and intraperitoneally in colorectal cancer patients. An overview. Acta Radiol Suppl (1990) 0.76
Tumor targeting with monoclonal antibody B72.3. Int J Rad Appl Instrum B (1989) 0.76
Reducing the incidence and managing the consequences of anastomotic leakage after rectal resection. Acta Chir Iugosl (2004) 0.75
Autonomic nerve damage in rectal cancer surgery. Eur J Surg Oncol (2001) 0.75
Two cases of colo-ovarian cyst fistula. Int J Colorectal Dis (1995) 0.75
Anorectal physiology measurements are of no value in clinical practice. True or false? Ann R Coll Surg Engl (1994) 0.75
Resection of rectal cancer: laparoscopy or open surgery? Ann R Coll Surg Engl (2010) 0.75
In-house management of diagnostic imaging equipment. Med Biol Eng Comput (1994) 0.75
Expression and activity of hexokinase in the early mouse embryo. Mol Hum Reprod (1996) 0.75
The media mystique. N HC Perspect Community (1995) 0.75
B-scan echo-amplitude measurement in patients with diffuse infiltrative liver disease. J Clin Ultrasound (1981) 0.75
Postgraduate multidisciplinary development program: impact on the interpretation of pelvic MRI in patients with rectal cancer: a clinical audit in West Denmark. Dis Colon Rectum (2011) 0.75
Strangulated external hernia. Trop Doct (1988) 0.75
ECG compression: evaluation of FFT, DCT, and WT performance. Australas Phys Eng Sci Med (1998) 0.75
Australian Dermatopathology Society. Widespread papules, ulcers and atrophic lesions. Australas J Dermatol (1993) 0.75
Use of liposoluble contrast material to separate left renal and splenic parenchyma on computed tomography. J Comput Assist Tomogr (1980) 0.75
Minimizing the risks of central venous catheterization. Br J Hosp Med (1988) 0.75
Tumor targeting with monoclonal antibody B72.3: experimental and clinical results. Cancer Treat Res (1990) 0.75
Abdominal deliveries in Third World. Lancet (1987) 0.75
Dental voluntary relief work in Jamaica. J Ir Dent Assoc (1994) 0.75
Case report: characteristic ultrasonographic appearance of a large renal oncocytoma. Clin Radiol (1991) 0.75
A monoclonal antibody (B72.3) to adenocarcinoma of the colon and related tumors. Prog Clin Biol Res (1989) 0.75
The use of cardiac output monitoring to guide the administration of intravenous fluid during hyperthermic intraperitoneal chemotherapy. Colorectal Dis (2013) 0.75
Dinner goes to war: the long battle for edible combat rations is finally being won. Am Herit Invent Technol (1998) 0.75
Vasodilator correction of hypotension in the postoperative period. South Med J (1979) 0.75
The role of nutritional support in the management of a high-output stoma. Nutrition (1995) 0.75
Spontaneous regression of cutaneous metastases of squamous cell carcinoma. QJM (2013) 0.75
FEM model for evaluating buttock tissue response under sitting load. Conf Proc IEEE Eng Med Biol Soc (2004) 0.75